コンテンツへスキップ
Merck
すべての画像(1)

主要文書

安全性情報

R304-05A

Sigma-Aldrich

Rat Aortic Endothelial Cells: RAOEC, adult

別名:

RAOEC cells

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
41106514
NACRES:
NA.81

由来生物

rat aorta (adult)

包装

pkg of 500,000 cells

メーカー/製品名

Cell Applications, Inc

成長モード

Adherent

形態

Endothelial

テクニック

cell culture | mammalian: suitable

関連疾患

diabetes; cardiovascular diseases

保管温度

−196°C

詳細

Lot specific orders are not able to be placed through the web. Contact your local sales rep for more details.


RAOEC from Cell Applications, Inc. provide a useful model system to study many aspects of cardiovascular function and disease. Co-culture of the artery endothelial cells with species-matched smooth muscle cells provides an ideal model for studying the interaction between these two cell types.

RAOEC from Cell Applications, Inc. have been utilized in a number of research publications to:

  • Investigate critical signaling pathways and mechanisms relevant to proper endothelial function, such as angiogenesis, proliferation, permeability, and search for beneficial modulators for therapeutic use (Sorensen, 2008; Liu, 2009; Makino, 2009; Masuda, 2012; Gros, 2013; Nguen, 2013)
  • Elucidate molecular mechanisms of various cardiovascular risk factors, including those associated with diabetes, polycystic kidney disease, treatment for allograft rejection and vascular ER stress (Makino, 2008; Chiasson, 2011, Ren, 2011; Padilla, 2013)
  • Provide a gold standard control for endothelial markers vWF and PECAM/CD31 expression (Hanley, 2008; Imamura, 2010)
  • Develop drug delivery system for thrombolytic treatment (Mei, 2010)and methods for cardiac regeneration (Lionetti, 2010); design better vascular implants (Ibrahim, 2008; Yao, 2008; Duffy, 2011) and bone tissue engineering (Hamid, 2014)


Additionally, RAOEC from Cell Applications, Inc. were used to investigate the reasons for differential effects of Intermedin (IMD) on permeability of endothelial cells from different vascular beds (Aslam, 2011). Specifically, it was shown that IMD increased permeability of rat coronary microvascular endothelial cells by inducing loss of VE-cadherin from cel-cell junctions, but it reduced permeability of RAOEC and HUVECs because in those cell types IMD instead caused accumulation of VE-cadherin in cell-cell junctions. These differential effects of IMD on VE-cadherin are explained by the fact that, although IMD activates cAMP/PKA and inhibits RhoA/ROCK pathways leading to rearrangement of actin in both cell types, it only causes downstream Rac1 inhibition in rat coronary microvascular endothelial cells, but not in RAOEC or HUVEC. These results highlight the fundamental differences between endothelial cells from different vascular beds and/or microvascular vs. macrovascular endothelia.

細胞株の由来

Aorta

アプリケーション

Cardiovascular function, studies on immune system and graft rejection, development of 3D endothelialized engineered tissues, drug discovery, stent-graft compatibility testing.

構成

Rat Endothelial Cell Basal Medium that contains 10% FBS and 10% DMSO

品質

Each lot was tested for proper morphology, Population Doublings, Negative for HIV, Hepatitis B, Hepatitis C, mycoplasma, bacteria, and fungi.

調製ノート

  • 3rd passage, >500,000 cells in Rat Endothelial Cell Basal Medium that contains 10% FBS and 10% DMSO
  • Can be cultured at least to 6th passage

継代と培養方法

Please refer to the RAOEC Culture Protocol.

保管分類コード

10 - Combustible liquids

WGK

WGK 1

引火点(°F)

Not applicable

引火点(℃)

Not applicable


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

労働安全衛生法名称等を表示すべき危険物及び有害物

名称等を表示すべき危険物及び有害物

労働安全衛生法名称等を通知すべき危険物及び有害物

名称等を通知すべき危険物及び有害物

Jan Code

R304-05A:


最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 資料 section.

サポートが必要な場合は、お問い合わせください カスタマーサポート

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Mikhail A Kaplan et al.
Journal of biomaterials science. Polymer edition, 31(11), 1405-1420 (2020-04-24)
The novelty of the work lies in the creation and study of the physical and biological properties of biodegradable polymer coatings for stents based on poly(lactic-co-glycolic acid) (PLGA). Polymer coatings are capable of prolonged and directed release of molecules with

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)